Wildhagen MF - Search Results

1

Comparison of screen detected and clinically diagnosed prostate cancer in the European randomized study of screening for prostate cancer, section rotterdam.

van der Cruijsen-Koeter IW, Vis AN, Roobol MJ, Wildhagen MF, de Koning HJ, van der Kwast TH, Schröder FH. van der Cruijsen-Koeter IW, et al. Among authors: wildhagen mf. J Urol. 2005 Jul;174(1):121-5. doi: 10.1097/01.ju.0000162061.40533.0f. J Urol. 2005. PMID: 15947595 Clinical Trial.

2

Prostate-specific antigen change in the European Randomized Study of Screening for Prostate Cancer, section Rotterdam.

Raaijmakers R, Wildhagen MF, Ito K, Pàez A, de Vries SH, Roobol MJ, Schröder FH. Raaijmakers R, et al. Among authors: wildhagen mf. Urology. 2004 Feb;63(2):316-20. doi: 10.1016/j.urology.2003.09.028. Urology. 2004. PMID: 14972481

3

Prostate cancer detection in the prostate specific antigen range of 2.0 to 3.9 ng/ml: value of percent free prostate specific antigen on tumor detection and tumor aggressiveness.

Raaijmakers R, Blijenberg BG, Finlay JA, Rittenhouse HG, Wildhagen MF, Roobol MJ, Schröder FH. Raaijmakers R, et al. Among authors: wildhagen mf. J Urol. 2004 Jun;171(6 Pt 1):2245-9. doi: 10.1097/01.ju.0000127731.56103.50. J Urol. 2004. PMID: 15126795

4

Incidence and follow-up of patients with focal prostate carcinoma in 2 screening rounds after an interval of 4 years.

Postma R, de Vries SH, Roobol MJ, Wildhagen MF, Schröder FH, van der Kwast TH. Postma R, et al. Among authors: wildhagen mf. Cancer. 2005 Feb 15;103(4):708-16. doi: 10.1002/cncr.20840. Cancer. 2005. PMID: 15648082 Free article.

5

Digital rectal examination is no longer necessary in the routine follow-up of men with undetectable prostate specific antigen after radical prostatectomy: the implications for follow-up.

Chaplin BJ, Wildhagen MF, Schroder FH, Kirkels WJ, Bangma CH. Chaplin BJ, et al. Among authors: wildhagen mf. Eur Urol. 2005 Dec;48(6):906-10. doi: 10.1016/j.eururo.2005.07.006. Epub 2005 Aug 2. Eur Urol. 2005. PMID: 16126322

6

Randomized, double-blind, placebo-controlled crossover study in men with prostate cancer and rising PSA: effectiveness of a dietary supplement.

Schröder FH, Roobol MJ, Boevé ER, de Mutsert R, Zuijdgeest-van Leeuwen SD, Kersten I, Wildhagen MF, van Helvoort A. Schröder FH, et al. Among authors: wildhagen mf. Eur Urol. 2005 Dec;48(6):922-30; discussion 930-1. doi: 10.1016/j.eururo.2005.08.005. Epub 2005 Oct 17. Eur Urol. 2005. PMID: 16263208 Clinical Trial.

7

Tumor characteristics and prognostic factors in two subsequent screening rounds with four-year interval within prostate cancer screening trial, ERSPC Rotterdam.

van der Cruijsen-Koeter IW, Roobol MJ, Wildhagen MF, van der Kwast TH, Kirkels WJ, Schröder FH. van der Cruijsen-Koeter IW, et al. Among authors: wildhagen mf. Urology. 2006 Sep;68(3):615-20. doi: 10.1016/j.urology.2006.03.015. Urology. 2006. PMID: 17010732 Clinical Trial.

8

hK2 and free PSA, a prognostic combination in predicting minimal prostate cancer in screen-detected men within the PSA range 4-10 ng/ml.

Raaijmakers R, de Vries SH, Blijenberg BG, Wildhagen MF, Postma R, Bangma CH, Darte C, Schröder FH. Raaijmakers R, et al. Among authors: wildhagen mf. Eur Urol. 2007 Nov;52(5):1358-64. doi: 10.1016/j.eururo.2007.04.037. Epub 2007 Apr 20. Eur Urol. 2007. PMID: 17499425 Clinical Trial.

9

Prostate-specific antigen (PSA) isoform p2PSA in combination with total PSA and free PSA improves diagnostic accuracy in prostate cancer detection.

Jansen FH, van Schaik RH, Kurstjens J, Horninger W, Klocker H, Bektic J, Wildhagen MF, Roobol MJ, Bangma CH, Bartsch G. Jansen FH, et al. Among authors: wildhagen mf. Eur Urol. 2010 Jun;57(6):921-7. doi: 10.1016/j.eururo.2010.02.003. Epub 2010 Feb 13. Eur Urol. 2010. PMID: 20189711

10

Complication rates and risk factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate within a population-based screening program.

Raaijmakers R, Kirkels WJ, Roobol MJ, Wildhagen MF, Schrder FH. Raaijmakers R, et al. Among authors: wildhagen mf. Urology. 2002 Nov;60(5):826-30. doi: 10.1016/s0090-4295(02)01958-1. Urology. 2002. PMID: 12429309

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

84 results

Search Page